The online version of this article (doi:10.1186/1476-7120-10-50) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
KO and MI carried out subject recruitment and analyzed data. MK and RT analyzed data and wrote the manuscript. TW, NO, SW, TK, TK, and YG performed ultrasound analysis. MA, KN, GT, TN, SW and SM analyzed data. All authors read and approved the final manuscript.
The aim of this study was to define the independent determinants of left atrial appendage (LAA) thrombus among various echocardiographic parameters measured by Velocity Vector Imaging (VVI) in patients with nonvalvular atrial fibrillation (AF) receiving warfarin, particularly in patients with a low CHADS2 score.
LAA emptying fraction (EF) and LAA peak longitudinal strain were measured by VVI using transesophageal echocardiography in 260 consecutive patients with nonvalvular persistent AF receiving warfarin. The patients were divided into two groups according to the presence (n=43) or absence (n=217) of LAA thrombus. Moreover, the patients within each group were further divided into subgroups according to a CHADS2 score ≤1.
Multivariate logistic regression analysis showed that LAAEF was an independent determinant of LAA thrombus in the subgroup of 140 with a low CHADS2 score. Receiver operating characteristics curve analysis showed that an LAAEF of 21% was the optimal cutoff value for predicting LAA thrombus.
LAA thrombus formation depended on LAA contractility. AF patients with reduced LAA contractile fraction (LAAEF ≤21%) require strong anticoagulant therapy to avoid thromboembolic events regardless of a low CHADS2 score (≤1).
Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, Kääb S, Schotten U, Wegscheider K, Boriani G, Ezekowitz M, Diener H, Heidbuchel H, Lane D, Mont L, Willems S, Dorian P, Vardas P, Breithardt G, Camm AJ: Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference. Thromb Haemost. 2011, 106: 1012-1019. 10.1160/TH11-07-0517 CrossRefPubMed
Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ, for the ACTIVE W investigators: Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy. J Am Coll Cardiol. 2007, 50: 2156-2161. 10.1016/j.jacc.2007.07.076 CrossRefPubMed
Gulløv AL, Koefoed BG, Petersen P, Pedersen TS, Andersen ED, Godtfredsen J, Boysen G: Fixed mini-dose warfarin and aspirin alone and in combination versus adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study. Arch Intern Med. 1998, 158: 1513-1521. 10.1001/archinte.158.14.1513 CrossRefPubMed
Gorin L, Fauchier L, Nonin E, de Labriolle A, Haguenoer K, Cosnay P, Babuty D, Charbonnier B: Antithrombolic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score =1. Thromb Haemostasis. 2010, 103: 833-840. 10.1160/TH09-10-0746. CrossRef
Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I, Gili S, Horton R, Sanchez JE, Bai R, Mohanty S, Pump A, Cereceda Brantes M, Gallinghouse GJ, Burkhardt JD, Cesarani F, Scaglione M, Natale A, Gaita F: Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012, 60: 531-538. 10.1016/j.jacc.2012.04.032 CrossRefPubMed
Bernhardt P, Schnidt H, Hammerstingl C, Luderitz B, Omran H: Patients at high risk with atrial fibrillation: a prospective serial follow-up during 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Soc Echocardiogr. 2005, 18: 919-924. 10.1016/j.echo.2005.01.028 CrossRefPubMed
Pirat B, Khoury DS, Hartly CJ, Tiller L, Rao L, Schulz DG, Nagueh SF, Zoghbi WA: A novel feature-tracking echocardiographic method for the quantification of regional myocardial function: validation in an animal model of ischemia-reperfusion. J Am Coll Cardiol. 2008, 51: 651-659. 10.1016/j.jacc.2007.10.029 CrossRefPubMedPubMedCentral
Hirose T, Kawasaki M, Tanaka R, Ono K, Watanabe T, Iwama M, Noda T, Watanabe S, Takemura G, Minatoguchi S: Left atrial function assessed by speckle tracking echocardiography as a predictor of new-onset non-valvular atrial fibrillation: results from a prospective study in 580 adults. Eur Heart J - Card Img. 2012, 3: 243-250. CrossRef
Iwama M, Kawasaki M, Tanaka R, Ono K, Watanabe T, Hirose T, Noda T, Watanabe S, Takemura G, Minatoguchi S: Left atrial appendage emptying fraction assessed by a feature-tracking echocardiographic method is a determinant of thrombus in patients with nonvalvular atrial fibrillation. J Cardiol. 2012, 59: 329-336. 10.1016/j.jjcc.2012.01.002 CrossRefPubMed
JCS: Guidelines for pharmacotherapy of atrial fibrillation. Circ J. 2008, 72 (Suppl): 1581-1638.
Henry WL, DeMaria A, Gramiak R, King DL, Kisslo JA, Popp RL, Sahn DJ, Schiller NB, Tajik A, Teichholz LE, Weyman AE: Report of the American Society of Echocardiography Committee, on Nonmencature and Standards in Two-Dimensional Echocardiography. Circulation. 1980, 62: 21-27.
Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Chamber Quantification Writing Group; American Society of Echocardiography’s Guigelines and Standards Committee; European Association of Echocardiography: Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005, 18: 1440-1463. 10.1016/j.echo.2005.10.005 CrossRefPubMed
Ono K, Kawasaki M, Tanaka R, Segawa T, Matsuo H, Watanabe S, Takemura G, Minatoguchi S: Integrated backscatter and intima-media thickness of the thoracic aorta evaluated by transechocardiography in hypercholesterolemic patients: effect of pitavastatin therapy. Ultrasound Med Biol. 2009, 35: 193-200. 10.1016/j.ultrasmedbio.2008.08.011 CrossRefPubMed
Veinot JP, Harrity PJ, Gentile F, Khandheria BK, Bailey KR, Eickholt JT, Seward JB, Tajik AJ, Edwards WD: Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy heart; implications for echocardiographic examination. Circulation. 1997, 96: 3112-3115. 10.1161/01.CIR.96.9.3112 CrossRefPubMed
Mugge A, Kuhn H, Nikutta P, Grote J, Lopez JA, Daniel WG: Assessment of left atrial appengage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. J Am Coll Cardiol. 1994, 23: 599-607. 10.1016/0735-1097(94)90743-9 CrossRefPubMed
Oldgren J, Alings M, Darius H, Diener H-C, Eikelboom J, Ezekowitz MD, Kamensky G, Reilly PA, Yang S, Yusuf S, Wallentin L, Connolly SJ: RE-LY Investigators. Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving Dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial. Ann Intern Med. 2011, 155: 660-667. CrossRefPubMed
Yamashita E, Takamatsu H, Tada H, Toide H, Okaniwa H, Takemura N, Sasaki T, Miki Y, Fuke E, Hayashi T, Sakamoto T, Nakamura K, Fukazawa R, Sato C, Goto K, Kaseno K, Kumagai K, Naito S, Hoshizaki H, Oshima S: Transesophageal echocardiography for thrombus screening prior to left atrial catheter ablation. Circ J. 2010, 74: 1081-1086. 10.1253/circj.CJ-09-1002 CrossRefPubMed
- Motion of left atrial appendage as a determinant of thrombus formation in patients with a low CHADS2 score receiving warfarin for persistent nonvalvular atrial fibrillation
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II